Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Radiomics-based Hepatic Venous Pressure Gradient (rHVPG) for Clinically Significant Portal Hypertension
Brief Summary: This is a prospective, multi-center trial conducted at 10 high-volume liver centers in China designed to determine the diagnostic performance of radiomics-based hepatic venous pressure gradient (rHVPG) (investigational technology) by CT angiography (CTA) for noninvasive assessment of the clinically significant portal hypertension (CSPH) in patients with cirrhosis. Direct hepatic venous pressure gradient (HVPG) measurement by means of catheterization of a hepatic vein with a balloon catheter is the gold-standard method to assess the presence of CSPH, which is defined as HVPG≥10 mmHg.